ArticlemedRxiv : the preprint server for health sciences2024
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events.
Tigran Makunts et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.